Arvinas, Inc. (ARVN)

10.98 -0.02 (-0.23%) USD  |  NASDAQ  |  Apr 15, 16:00
10.98 0.00 (0.00%) After-Hours: 20:00
More

Arvinas Research and Development Expense (Annual) : 282.90M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ARVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Pfizer Inc. 10.25B
EyePoint Plc 221.04M
Apellis Pharmaceuticals, Inc. 295.85M
Elanco Animal Health, Inc. 368.00M
Gossamer Bio, Inc. 174.07M